Lv1
20 积分 2026-04-23 加入
A series of novel, highly potent, and orally bioavailable next-generation tricyclic peptide PCSK9 inhibitors
2个月前
已完结
Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor
2个月前
已完结
Orally bioavailable macrocyclic peptide that inhibits binding of PCSK9 to the low density lipoprotein receptor
2个月前
已完结
New Oral PCSK9 Inhibitor: "MK-0616"
2个月前
已完结
皖公网安备34019202002308
